Artivion, Inc. Common Stock (AORT)

Frequently Asked Questions About Artivion, Inc. Common Stock (AORT)

Can investors buy stock in Artivion, Inc.?

Yes, investors can buy stock in Artivion, Inc., as it is publicly traded on the New York Stock Exchange under the ticker symbol AORT. Potential investors should conduct thorough research and consider the company's financial health and market position before making an investment decision.

Does Artivion, Inc. engage in any research and development?

Yes, research and development are critical components of Artivion, Inc.'s operations. The company invests significantly in R&D to foster innovation, develop new products, and enhance existing technologies, ensuring they stay at the forefront of advancements in the cardiac and vascular device market.

How does Artivion, Inc. approach innovation?

Artivion, Inc. approaches innovation through a commitment to research and development, engaging with leading medical professionals to identify their needs. This collaborative approach enables the company to develop cutting-edge technologies and continuously improve its product offerings, addressing the evolving landscape of cardiac healthcare.

How does Artivion, Inc. ensure product safety?

Artivion, Inc. ensures product safety through rigorous testing, adherence to industry standards, and compliance with regulatory guidelines. The company conducts extensive preclinical and clinical studies to evaluate the safety and efficacy of its devices before they are marketed for use.

How does Artivion, Inc. handle customer feedback?

Artivion, Inc. values customer feedback as an essential part of its product development and improvement processes. The company actively seeks input from healthcare professionals and patients to refine its devices and services, ensuring that they meet the needs of users and improve patient care standards.

Is Artivion, Inc. publicly traded?

Yes, Artivion, Inc. is publicly traded on the New York Stock Exchange under the ticker symbol AORT. As a publicly traded company, it is subject to regulatory requirements and provides financial disclosures, allowing investors to evaluate its performance and stability.

What are the financial highlights of Artivion, Inc.?

Financial highlights for Artivion, Inc. include growth in revenue and market share within the medical device sector. The company regularly reports its financial performance, outlining key metrics such as sales growth, profitability, and strategic investments, which are crucial indicators of its market position and sustainability.

What are the growth prospects for Artivion, Inc.?

Artivion, Inc. has considerable growth prospects due to the increasing prevalence of cardiovascular diseases and the growing demand for innovative surgical solutions. Ongoing research and development focus on introducing new technologies and expanding their product portfolio to address unmet medical needs, positioning them for sustained growth in the market.

What challenges does Artivion, Inc. face?

Artivion, Inc. faces challenges typical of the medical device industry, including regulatory hurdles, competition from larger companies, and the need for continuous innovation. Additionally, changes in healthcare policies and reimbursement strategies can also impact their market performance and growth strategies.

What does Artivion, Inc. do?

Artivion, Inc. is a medical device company that specializes in developing innovative technologies for cardiac and vascular surgery. They focus on creating advanced solutions in areas such as aortic and peripheral vascular disease, utilizing their expertise in bioengineered technologies to improve surgical outcomes and patient care.

What is Artivion, Inc.'s approach to sustainability?

Artivion, Inc. is committed to sustainability through responsible manufacturing practices and a focus on reducing waste and energy consumption. The company also aims to create products that contribute to better health outcomes for patients, indirectly supporting environmental sustainability by promoting less invasive surgical options.

What is the company's mission?

Artivion, Inc.'s mission is to improve the lives of patients with cardiovascular diseases by providing innovative, minimally invasive surgical solutions. The company aims to enhance surgical outcomes and promote faster recovery through continuous innovation and commitment to excellence in patient care.

What markets does Artivion, Inc. serve?

Artivion, Inc. serves global markets in the healthcare sector, focusing primarily on hospitals and surgical centers that perform cardiac and vascular procedures. Their innovative devices are used by cardiovascular surgeons to improve surgical outcomes for patients suffering from various heart and vascular conditions.

What regulatory approvals has Artivion, Inc. received for its products?

Artivion, Inc. has received various regulatory approvals for its medical devices, including clearance from the U.S. Food and Drug Administration (FDA) for its innovative technologies. Additionally, the company navigates international regulatory processes to ensure compliance for global distribution of its products.

What types of products does Artivion, Inc. offer?

Artivion, Inc. offers a variety of products focused on cardiac and vascular surgery, including medical devices for aortic repair, grafts, and various surgical tools. Their flagship products incorporate advanced biomaterials and technologies, aimed at reducing complications and improving recovery times for patients.

When was Artivion, Inc. founded?

Artivion, Inc. was founded in 2005. Since its inception, the company has been dedicated to advancing cardiac surgical technologies and has made significant strides in enhancing patient outcomes through its innovative products and solutions.

Where is Artivion, Inc. headquartered?

Artivion, Inc. is headquartered in Kennesaw, Georgia, USA. The location of the headquarters allows the company to be in close proximity to major medical institutions and research hubs, facilitating collaboration and innovation in the medical device field.

Who are the competitors of Artivion, Inc.?

Artivion, Inc. competes with several companies in the medical device industry specializing in cardiac and vascular surgery. Key competitors include Medtronic, Edwards Lifesciences, and Boston Scientific, among others, which also focus on developing advanced technologies for cardiac interventions.

Who are the key executives at Artivion, Inc.?

Artivion, Inc. is led by a team of experienced executives with significant backgrounds in the medical device industry. Key executives include the CEO, who drives the strategic vision of the company, and other leaders in marketing, finance, and research, who collectively steer the company's growth and innovation.

What is the current price of Artivion, Inc. Common Stock?

The current price of Artivion, Inc. Common Stock is 25.05

When was Artivion, Inc. Common Stock last traded?

The last trade of Artivion, Inc. Common Stock was at 7:00 pm EDT on April 2nd, 2025